47 results about "Lactose Powder" patented technology

The invention belongs to a production technology of a dairy product and particularly relates to a method for preparing WPC and lactose powder simultaneously by whey. The main steps are as follows: (1) primary ultrafiltration: a whey solution passes through an ultrafiltration membrane with the molecular weight cutoff of 5,000 to 10,000Da; (2) moisturization and ultrafiltration: when the membrane flux is reduced to 60% to 80% of the primary membrane flux, continuously supplementing 2 to 5 times of deionized water based on the volume of a concentrated solution into the concentrated solution to obtain a permeate and the concentrated solution; (3) preparing the whey protein powder: ultrafiltrating and drying the whey protein powder to obtain the WPC; and (4) refining the lactose powder: adding the evaporated and condensed ultrafiltration permeate into food grade ethanol till the final volume fraction is 40 to 60%, collecting, washing and drying the precipitate to obtain the lactose. According to the method for preparing the WPC and the lactose powder simultaneously by the whey, WPC with high protein content and lactose powder with high purity are obtained simultaneously through the ultrafiltration as a main separating method, and the deionized water and the food grade ethanol are only added in the whole process but the substances including external salt, acid and alkali and the like are not added.

The invention relates to a biological agent for improving human body intestinal floras and a preparing method thereof. The biological agent comprises 45-68 parts by weight of lactic acid bacteria, 30-50 parts by weight of isomerized lactose powder, 20-50 parts by weight of apple vinegar, 30-50 parts by weight of ferment and 10-30 parts by weight of dietary fiber. The biological agent is prepared by fully mixing the acetic acid bacteria, the apple vinegar and the dietary fiber by stirring, adding the isomerized lactose powder and the ferment, continuously stirring and mixing for 30-45 min, and sterilizing. Compared with the prior art, the biological agent is simple in composition and is capable of effectively promoting increase of bifidobacteria which are beneficial bacteria in intestinal tracts, allowing the lactic acid bacteria and the bifidobacteria to increase in a balance manner and inhibiting growth of putrefying bacteria and pathogenic bacteria, thus effectively balancing beneficial floras in the intestinal tracts. The biological agent is simple in preparing process, rapid in production of desired effects, wide in suitable population, low in medicine using amount, less in side effects, high in stability, long in shelf life, convenient in medicine taking, easy to carry, low in cost and suitable for large-scale production.

The invention discloses a milk tea tablet. The milk tea tablet is prepared from raw material in parts by weight: 10-14 parts of whole milk powder, 0.4-1.5 parts of black tea powder, 3-8 parts of sucrose powder, 3-15 parts of lactose powder, 0.2-0.5 part of sodium carboxymethyl cellulose, 0.0001-0.03 part of ethyl maltol, and 1-4 parts of corn starch. The invention also discloses a process for producing the milk tea tablet. The instant milk tea tablet has rich milk tea flavor, mellow mouth feeling, and moderate saccharinity; and the milk tea tablet prepared by the prescription is difficult to disintegrate, has stable structure, can be directly eaten or brewed to drink, and is an ideal leisure food. Meanwhile, the consumer can add coffee powder or chocolate powder and the like into the milk tea according to personal taste to form corresponding flavor milk tea.

The present invention discloses one kind of tiotropium bromide capsule atomized powder preparation, which includes tiotropium bromide or tiotropium bromide monohydrate in 0.04-1.5 wt% and fine lactose powder of size smaller than 15 microns for adsorbing tiotropium bromide or tiotropium bromide monohydrate. The present invention also provides the preparation process of the atomized powder preparation. The tiotropium bromide capsule atomized powder preparation has simple preparation process, excellent flowability and homogeneously distributed active component.

The invention provides a production method of sugarless fermented whey beverage. The method comprises the following steps: mixing whey powder and lactose powder, adding hot purified water, dissolving, boiling to sterilize, cooling, inoculating lactic acid bacteria, allowing fermentation, inoculating lactobacilli, allowing secondary fermentation, and chilling; mixing CMC and healthy sugar, dissolving in hot water and cooling; and mixing the resulting two mixtures, vigorously stirring, flavoring, supplementing water to the desired volume, homogenizing, sterilizing, and packaging under sterile conditions to obtain milk white sugarless fermented whey beverage. The sugarless fermented whey beverage can be preserved at 4 DEG C for about 7 days.

The present invention relates to the preparation of food products presented in the form of a bite-sized piece comprising a cereal-based core and a cheese coating. Said cheese snack is characterised in that it comprises a pre-layer coating positioned between the central part and the cheese coating layer; said pre-layer comprises a mixture of fatty substance having a melting point of between 30 and 34 DEG C and lactose powder; it is spherical in shape and its surface is smooth.

The invention discloses a Prulifloxacin composition. The composition comprises the following components: 130 to 135 parts of Prulifloxacin, 35 to 45 parts of lactose, 9 to 10 parts of hydroxypropyl cellulose, 1.5 to 2.5 parts of magnesium stearate and 15 to 20 parts of povidone K30. Quality and yield of the Prulifloxacin are greatly improved by adjusting parameters during synthesis, such as addition speed of reactants. The method for preparing the composition comprises the following steps of preparing solution of povidone K30 ethanol; uniformly mixing the Prulifloxacin with the hydroxypropyl cellulose, and crushing the mixture with mechanical crusher; screening, and screening crushed lactose; adding lactose into mixed powder of the Prulifloxacin and the hydroxypropyl cellulose, and uniformly mixing with a three-dimensional mixer; then adding the prepared solution of povidone K30; uniformly mixing, granulating, and straightening granules after drying; and adding the magnesium stearate into the prepared granules and uniformly mixing with the three-dimensional mixer. The composition prepared by the method has advantages of good quality, less disintegration time and high dissolution efficiency.

The invention discloses a blueberry fruit vinegar beverage good for improving human intestinal environment and promoting health. The blueberry fruit vinegar beverage is prepared from the following components in parts by weight: 145-150 parts of fresh and intact blueberry fruits, 140-145 parts of fresh and intact taxus chinensis fruits, 5-6 parts of stachyose, 11-12 parts of Se-enriched yeast, 14-15 parts of acetic acid bacteria, 9-10 parts of ester-production yeast, 4-5 parts of fungus polyphenol, 6-7 parts of isomerized lactose powder, 7-8 parts of seaweed enzymes, 5-6 parts of inulin, 5-6 parts of L-Arabinose, 5-6 parts of polydextrose and the like. The composite fruit vinegar beverage is prepared from nutritious taxus chinensis fruits and blueberry fruits prepared concentrated compound juice, pomace fermentation products and nutritional enhancement substances, is rich in nutrients such as amino acids, vitamins and the like, has higher nutritional value, can cooperate with the nutritional enhancement substances to promote rapid reproduction of useful intestine bacteria and accelerate intestinal peristalsis, and toxic metabolites in the intestine are discharged rapidly, therefore, effects of improving the human intestinal environment and promoting health are realized.

The invention discloses a method for extracting high-nutrient lactose from fresh milk, which comprises the following steps: 1) carrying out primary centrifugal operation on fresh milk to obtain skimmed milk; 2) carrying out microfiltration and secondary centrifugal operation to obtain milk serum, and carrying out ultrafiltration to obtain a first filtrate which passes through a first ultrafiltration membrane; 3) adding a chitosan-acetic acid solution into the first filtrate, and carrying out secondary ultrafiltration to obtain a second filtrate; 4) dropwisely adding the second filtrate into a 0.1-5 wt% sodium hydroxide solution, carrying out pressure filtration to obtain a first retention substance on the filter screen, dissolving the first retention substance in a 0.08-1.6 wt% hydrochloric acid solution, and carrying out nanofiltration to obtain a fourth filtrate; and 5) adding calcium chloride into the fourth filtrate solution, carrying out nanofiltration to obtain a fifth filtrate, and carrying out spray drying on the fifth filtrate solution to obtain lactose powder. The method solves the technical problem of difficulty in extraction due to the loss of the high-nutrient lactose.

The invention belongs to the field of medicines, and particularly discloses a production formula and technology of high-treatment-effect cyproheptadine hydrochloride tablets. The formula comprises thefollowing components in compounding ratio of 2g of cyproheptadine hydrochloride, 50-60g of lactose, 18-22g of starch, 2-2.5g of cellulose and 0.9-1.1g of magnesium stearate. The technology comprisesthe specific steps of S1, adding the cyproheptadine hydrochloride raw material in a micronizing machine set, performing micronizing, and crushing lactose; S2, performing mixing: mixing the obtained cyproheptadine hydrochloride with the lactose and the starch to obtain a mixture, and adding the mixture in a boiling pelletizer; S3, preparing an adhesive; S4, performing granulation; S5, shaping granules; S6, performing total mixing; and S7, performing tabletting and bottling. Production is performed based on a boiling-over granulation making technology, through disintegration characteristics of different auxiliary materials, the disintegration speed of medicines in different environment of bodies is controlled, blood medicine level in human bodies when the medicines are released in the humanbodies is consistent with that of original medicines, the production flow is simplified, besides, the product quality is improved, the release speed of main medicines is controlled, and the medicationsafety is guaranteed.

Disclosed is the 3D printing of pharmaceutical formulations, such as tablets, wherein a binder liquid is deposited dropwise on a layer of powder, with these steps being repeated, in one or more patterns, in order to generate a solid drug product. In accordance with the invention, the powder comprises lactose particles having a particle size distribution characterized by a D10 of at least 6 μm.

The invention discloses cough-relieving tablets which are prepared by carrying out dry granulation and tablet pressing on medicinal material extract paste powder, lactose powder, microcrystalline cellulose, pregelatinized starch, silicon dioxide, magnesium stearate and polyethylene glycol 4000. The invention further discloses a preparation method of the cough-relieving tablets, which comprises the following steps: firstly uniformly mixing the lactose powder, the pregelatinized starch and the medicinal material extract paste powder, and being uniformly mixed with the microcrystalline cellulose and the polyethylene glycol 4000; and carrying out the dry granulation on the mixed materials, preparing granules, then carrying out final mixing with the magnesium stearate and the silicon dioxide, and carrying out the tablet pressing for preparing the cough-relieving tablets. The tablets prepared by adopting the dry granulation and the tablet pressing can effectively improve the hardness and the stability of the tablets, solve the problems of unqualified disintegration time limit and unqualified microorganisms, further improve the product quality, lead the process flow to be simple, save energy, save cost and be suitable for industrial production.

A health-care food for delaying senility and regulating blood fat is prepared from lecithin, VE and the excipient prepared from calcium carbonate, calcium phosphate, cane sugar powder, lactose powder, sorbitol, gelatin, micropowdered silica gel, magnesium stearate and hydroxypropyl methylcellulose.

The invention discloses breadcrumbs for fried food. The breadcrumbs are prepared from the following components in parts by mass: 25-35 parts of flour, 10-15 parts of corn flour, 5-10 parts of wheat germ flour, 3-5 parts of walnut powder, 15-35 parts of water, 5-10 parts of oil, 3-5 parts of unsalted butter, 1-3 parts of condensed milk, 15-20 parts of powdered sugar and 1-3 parts of egg liquid. According to the breadcrumbs, the formula of common breadcrumbs is improved, the feeding speed is increased, the extrusion temperature is increased, the time required for extrusion and puffing of the paste is reduced, the excessive puffing proportion of the paste is greatly reduced, the bitter taste is reduced, and the crispy taste is improved at the same time.

The invention discloses a preparation method of glaangal and ganoderma lucidum health care beverage. The method comprises the following steps: firstly, preparing bitter caramon and ganoderma lucidum particles, secondly, preparing bitter caramon extract liquor, thirdly, preparing ganoderma lucidum extract liquor, fourthly, respectively obtaining bitter caramon embedding powder and ganoderma lucidum embedding powder, fifthly, uniformly mixing the bitter caramon embedding powder and ganoderma lucidum embedding powder obtaining in the fourth step with boxthorn powder, hawthorn fruit powder, lactose powder and maltodextrin, and sixthly, performing drying, pelletization and sieving, so as to obtain glaangal and ganoderma lucidum tea. The preparation method not only provides convenient glaangal and ganoderma lucidum healthy solid beverage for people, but also opens a new approach for the comprehensive utilization of valuable ganoderma lucidum resource, and provides a product with high market competitiveness for the health of the public.

The invention discloses traditional Chinese medicine granules capable of soothing liver, regulating qi, invigorating spleen and harmonizing stomach, and particularly relates to the technical field oftraditional Chinese medicines; the traditional Chinese medicine granules comprise the following raw materials: radix bupleuri, radix scutellariae, ginger processed pinellia, radix codonopsis, rhizomazingiberis recens, radix glycyrrhizae, fructus jujubae, fructus citri sarcodactylis, radix aucklandiae, fructus evodiae, malt and lactose. According to the granules, the normal effect of the Xiaochaihu Keli (a Chinese patent medicine name of radix bupleuri granules) can be ensured; fructus citri sarcodactylis, radix aucklandiae, fructus evodiae, malt and lactose can effectively enhance the effectsof soothing the liver, regulating qi, strengthening the spleen and harmonizing the stomach of the Xiaochaihu Keli; malt and lactose are used as supporting carriers, the stability of the medicine canbe enhanced, the storage time of the medicine is prolonged, lactose is easy to absorb, diffusion of effective substances in the medicine can be accelerated, efficacy is exerted faster, and medicine waste is reduced; medicinal effect loss can be effectively avoided, medicinal effect is guaranteed, and medicinal waste is reduced; and malt flour and lactose powder can be better combined with effective substances of traditional Chinese medicinal materials, so that the Xiaochaihu Keli are better in stability.